Article | Published:

Notch signaling is necessary for adult, but not fetal, development of RORγt+ innate lymphoid cells

Nature Immunology volume 12, pages 949958 (2011) | Download Citation

This article has been updated

Abstract

The transcription factor RORγt is required for the development of several innate lymphoid populations, such as lymphoid tissue–inducer cells (LTi cells) and cells that secrete interleukin 17 (IL-17) or IL-22. The progenitor cells as well as the developmental stages that lead to the emergence of RORγt+ innate lymphoid cells (ILCs) remain undefined. Here we identify the chemokine receptor CXCR6 as an additional marker of the development of ILCs and show that common lymphoid progenitors lost B cell and T cell potential as they successively acquired expression of the integrin α4β7 and CXCR6. Whereas fetal RORγt+ cells matured in the fetal liver environment, adult bone marrow–derived RORγt+ ILCs matured outside the bone marrow, in a Notch2-dependent manner. Therefore, fetal and adult environments influence the differentiation of RORγt+ cells differently.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Change history

  • 23 September 2011

    In the version of this article initially published, some labels in Figures 1 and 7, text on pages 950, 951, 956 and 957 and figure citations on page 952 were incorrect. In Figure 1c, bottom left, the middle label should be CD3-CXCR6+; in Figure 7a,b, the vertical axis label for the second column should be IL-7Rα and for the third column should be CD19; and in Figure 7d, the horizontal axis should include one arrow per column and the arrows for the middle and right columns should be labeled RORγt. On page 950, left column, the phrase "at double-negative state 3" should be deleted; on page 951, right column, penultimate line, the third genotype should be Cxcr6GFP/GFP; the legend to Figure 7a,b should read "...cells plated on OP9-DL4 stroma"; and on page 957, column 1, paragraph 2, the second sentence should end "...cells on OP9 cells." On page 952, right column, line 1, the first citation "(Fig. 3b)" should read "(data not shown)"; and on line 7, the citation "(Fig. 3e)" should read "(Fig. 3b)." The errors have been corrected in the HTML and PDF versions of the article.

References

  1. 1.

    & The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat. Immunol. 12, 21–27 (2011).

  2. 2.

    et al. Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells. Nature 463, 540–544 (2010).

  3. 3.

    et al. Ectopic lymphoid-organ development occurs through interleukin 7-mediated enhanced survival of lymphoid-tissue-inducer cells. Immunity 26, 643–654 (2007).

  4. 4.

    et al. Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature 397, 702–706 (1999).

  5. 5.

    , , , & Commitment to natural killer cells requires the helix-loop-helix inhibitor Id2. Proc. Natl. Acad. Sci. USA 98, 5164–5169 (2001).

  6. 6.

    et al. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 464, 1371–1375 (2010).

  7. 7.

    , & Innate immune cell populations function as initiators and effectors in Th2 cytokine responses. Trends Immunol. 31, 407–413 (2010).

  8. 8.

    et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 464, 1367–1370 (2010).

  9. 9.

    Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity. Immunity 31, 15–23 (2009).

  10. 10.

    , , , & Human NKp44+IL-22+ cells and LTi-like cells constitute a stable RORC+ lineage distinct from conventional natural killer cells. J. Exp. Med. 207, 281–290 (2010).

  11. 11.

    et al. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity 29, 958–970 (2008).

  12. 12.

    et al. RORγt and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells. Nat. Immunol. 10, 83–91 (2009).

  13. 13.

    et al. Influence of the transcription factor RORγt on the development of NKp46+ cell populations in gut and skin. Nat. Immunol. 10, 75–82 (2009).

  14. 14.

    et al. Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J. Exp. Med. 206, 35–41 (2009).

  15. 15.

    , , , & CD4+ lymphoid tissue-inducer cells promote innate immunity in the gut. Immunity 34, 122–134 (2011).

  16. 16.

    et al. Neonatal and adult CD4+CD3 cells share similar gene expression profile, and neonatal cells up-regulate OX40 ligand in response to TL1A (TNFSF15). J. Immunol. 177, 3074–3081 (2006).

  17. 17.

    et al. Function of CD4+CD3 cells in relation to B- and T-zone stroma in spleen. Blood 109, 1602–1610 (2007).

  18. 18.

    et al. Restoration of lymphoid organ integrity through the interaction of lymphoid tissue–inducer cells with stroma of the T cell zone. Nat. Immunol. 9, 667–675 (2008).

  19. 19.

    et al. Identification of multiple isolated lymphoid follicles on the antimesenteric wall of the mouse small intestine. J. Immunol. 168, 57–64 (2002).

  20. 20.

    et al. Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. Nature 456, 507–510 (2008).

  21. 21.

    et al. An essential function for the nuclear receptor RORγ(t) in the generation of fetal lymphoid tissue inducer cells. Nat. Immunol. 5, 64–73 (2004).

  22. 22.

    et al. Chemokine CXCL13 is essential for lymph node initiation and is induced by retinoic acid and neuronal stimulation. Nat. Immunol. 10, 1193–1199 (2009).

  23. 23.

    et al. Tyrosine kinase receptor RET is a key regulator of Peyer's patch organogenesis. Nature 446, 547–551 (2007).

  24. 24.

    , & Developing lymph nodes collect CD4+CD3LTb+ cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells. Immunity 7, 493–504 (1997).

  25. 25.

    et al. Requirement for RORγ in thymocyte survival and lymphoid organ development. Science 288, 2369–2373 (2000).

  26. 26.

    et al. Retinoid-related orphan receptor γ (RORγ) is essential for lymphoid organogenesis and controls apoptosis during thymopoiesis. Proc. Natl. Acad. Sci. USA 97, 10132–10137 (2000).

  27. 27.

    et al. The fetal liver counterpart of adult common lymphoid progenitors gives rise to all lymphoid lineages, CD45+CD4+CD3 cells, as well as macrophages. J. Immunol. 166, 6593–6601 (2001).

  28. 28.

    , & Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 91, 661–672 (1997).

  29. 29.

    et al. Expression of α4β7 integrin defines a distinct pathway of lymphoid progenitors committed to T cells, fetal intestinal lymphotoxin producer, NK, and dendritic cells. J. Immunol. 167, 2511–2521 (2001).

  30. 30.

    et al. Runx1/Cbfβ2 complexes are required for lymphoid tissue inducer cell differentiation at two developmental stages. J. Immunol. 186, 1450–1457 (2011).

  31. 31.

    et al. Lineage relationship analysis of RORγt+ innate lymphoid cells. Science 330, 665–669 (2010).

  32. 32.

    , & Shared dependence on the DNA-binding factor TOX for the development of lymphoid tissue-inducer cell and NK cell lineages. Nat. Immunol. 11, 945–952 (2010).

  33. 33.

    , , & Rearrangement of IgH genes in normal thymocyte development. J. Immunol. 140, 3228–3232 (1988).

  34. 34.

    et al. B lineage-specific regulation of V(D)J recombinase activity is established in common lymphoid progenitors. J. Exp. Med. 199, 491–502 (2004).

  35. 35.

    et al. Stage-specific expression of mucosal addressin cell adhesion molecule-1 during embryogenesis in rats. J. Immunol. 164, 2463–2471 (2000).

  36. 36.

    , , , & A developmental switch in lymphocyte homing receptor and endothelial vascular addressin expression regulates lymphocyte homing and permits CD4+CD3 cells to colonize lymph nodes. Proc. Natl. Acad. Sci. USA 93, 11019–11024 (1996).

  37. 37.

    et al. Role for CXCR6 in recruitment of activated CD8+ lymphocytes to inflamed liver. J. Immunol. 174, 277–283 (2005).

  38. 38.

    et al. Expression cloning of the STRL33/BONZO/TYMSTRligand reveals elements of CC, CXC, and CX3C chemokines. J. Immunol. 166, 5145–5154 (2001).

  39. 39.

    , , , & A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat. Immunol. 1, 298–304 (2000).

  40. 40.

    et al. Morphine induces gene expression of CCR5 in human CEMx174 lymphocytes. J. Biol. Chem. 275, 31305–31310 (2000).

  41. 41.

    , & Overlapping roles of CXCL13, interleukin 7 receptor α, and CCR7 ligands in lymph node development. J. Exp. Med. 197, 1191–1198 (2003).

  42. 42.

    et al. Cooperating mechanisms of CXCR5 and CCR7 in development and organization of secondary lymphoid organs. J. Exp. Med. 197, 1199–1204 (2003).

  43. 43.

    et al. Lymphoid precursors in intestinal cryptopatches express CCR6 and undergo dysregulated development in the absence of CCR6. J. Immunol. 171, 2208–2215 (2003).

  44. 44.

    , , , & A tissue-specific endothelial cell molecule involved in lymphocyte homing. Nature 331, 41–46 (1988).

  45. 45.

    et al. Regulated expression of nuclear receptor RORγt confers distinct functional fates to NK cell receptor-expressing RORγt+ innate lymphocytes. Immunity 33, 736–751 (2010).

  46. 46.

    et al. Lunatic and manic fringe cooperatively enhance marginal zone B cell precursor competition for delta-like 1 in splenic endothelial niches. Immunity 30, 254–263 (2009).

  47. 47.

    & Expression of Notch pathway components in fetal and adult mouse small intestine. Gene Expr. Patterns 2, 247–250 (2002).

  48. 48.

    , & Frequency of VH81x usage during B cell development: Initial decline in usage is independant of Ig heavy chain cell surface expression. J. Immunol. 156, 2077–2084 (1996).

  49. 49.

    , & Enumeration and characterization of DJH rearrangements in fetal liver. EMBO J. 11, 1891–1899 (1992).

Download references

Acknowledgements

We thank J. Bertrand and R. Lo Man for comments on the manuscript; F. Geissmann (King's College London) for Cxcr6GFP/+ mice; and S. Ezine (Institut National de la Santé et de la Recherche Médicale U591) for nude mice. Supported by the Ministère de la Recherche (C.P.), Association pour la Recherche sur le Cancer (C.P.), Swiss National Science Foundation (S.S.), Fondation Santé (S.S.), Institut Pasteur (A.C., L.B. and A.L.), Université Paris Diderot (R.G., C.P. and S.C.), Institut National de la Santé et de la Recherche Médicale (A.C.) and Agence Nationale de Recherches (A.C., R.G. and S.S.).

Author information

Affiliations

  1. Institut Pasteur, Unité de Lymphopoièse, Paris, France.

    • Cécilie Possot
    • , Sandrine Schmutz
    • , Sylvestre Chea
    • , Laurent Boucontet
    • , Ana Cumano
    •  & Rachel Golub
  2. L'Université Paris Diderot, Sorbonne Paris Cité (Cellule Pasteur), Paris, France.

    • Cécilie Possot
    • , Sylvestre Chea
    •  & Rachel Golub
  3. Institut National de la Santé et de la Recherche Médicale U668, Paris, France.

    • Cécilie Possot
    • , Sandrine Schmutz
    • , Sylvestre Chea
    • , Laurent Boucontet
    • , Ana Cumano
    •  & Rachel Golub
  4. Institut Pasteur, Plate Forme de Cytometrie, Paris, France.

    • Anne Louise

Authors

  1. Search for Cécilie Possot in:

  2. Search for Sandrine Schmutz in:

  3. Search for Sylvestre Chea in:

  4. Search for Laurent Boucontet in:

  5. Search for Anne Louise in:

  6. Search for Ana Cumano in:

  7. Search for Rachel Golub in:

Contributions

C.P. and R.G. designed the experiments; C.P. and S.S. did the experiments with assistance from L.B. for quantitative RT-PCR, S.C. for supplementary figures, and A.L. for cell sorting; and C.P. and R.G. analyzed the data and wrote the manuscript with contributions from A.C.

Competing interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to Rachel Golub.

Supplementary information

PDF files

  1. 1.

    Supplementary Text and Figures

    Supplementary Figures 1–13

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/ni.2105

Further reading